Page last updated: 2024-08-24

oseltamivir and Autoimmune Thrombocytopenia

oseltamivir has been researched along with Autoimmune Thrombocytopenia in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (42.86)24.3611
2020's4 (57.14)2.80

Authors

AuthorsStudies
Ahmadi, Z; Chong, BH; Leung, HHL; Perdomo, JS; Wong, R; Yan, F; Zheng, SS1
Cantú-Rodríguez, OG; Colunga-Pedraza, JE; Colunga-Pedraza, PR; De la Garza-Salazar, F; Gómez-Almaguer, D; Gómez-De León, A; Peña-Lozano, SP; Sánchez-Rendón, E; Santana-Hernández, P1
Neunert, C1
Han, P; Hou, M; Hou, Y; Li, D; Liu, X; Peng, J; Qiu, J; Shao, L; Sun, L; Wang, J; Wang, Z; Xu, M; Yu, Y; Yuan, C; Zhao, H; Zhou, H1
Hou, M; Ni, H; Peng, J; Qin, P; Shao, L; Wu, Y; Zhou, H1
Álvarez-Román, MT; Bernardino, JI; Butta, NV; Fernández-Bello, I; Jiménez-Yuste, V; Lozano, ML; Martín-Salces, M; Rivas Pollmar, MI1
Alioglu, B; Dallar, Y; Ozen, C; Selver, B; Tasar, A1

Reviews

1 review(s) available for oseltamivir and Autoimmune Thrombocytopenia

ArticleYear
Oseltamivir as rescue therapy for persistent, chronic, or refractory immune thrombocytopenia: a case series and review of the literature.
    Journal of thrombosis and thrombolysis, 2022, Volume: 54, Issue:2

    Topics: Humans; Oseltamivir; Prospective Studies; Purpura, Thrombocytopenic, Idiopathic; Thrombocytopenia; Treatment Outcome

2022

Trials

1 trial(s) available for oseltamivir and Autoimmune Thrombocytopenia

ArticleYear
Dexamethasone plus oseltamivir versus dexamethasone in treatment-naive primary immune thrombocytopenia: a multicentre, randomised, open-label, phase 2 trial.
    The Lancet. Haematology, 2021, Volume: 8, Issue:4

    Topics: Administration, Oral; Adult; China; Dexamethasone; Drug Therapy, Combination; Enzyme Inhibitors; Female; Follow-Up Studies; Glucocorticoids; Hemorrhage; Humans; Intention to Treat Analysis; Male; Middle Aged; Oseltamivir; Platelet Count; Purpura, Thrombocytopenic, Idiopathic; Safety; Treatment Outcome

2021

Other Studies

5 other study(ies) available for oseltamivir and Autoimmune Thrombocytopenia

ArticleYear
Antiplatelet antibody predicts platelet desialylation and apoptosis in immune thrombocytopenia.
    Haematologica, 2022, 09-01, Volume: 107, Issue:9

    Topics: Animals; Antibodies; Apoptosis; Autoantibodies; Blood Platelets; Humans; Mice; Oseltamivir; Platelet Glycoprotein GPIb-IX Complex; Platelet Glycoprotein GPIIb-IIIa Complex; Purpura, Thrombocytopenic, Idiopathic; Thrombocytopenia

2022
Looking long-term: an unmet need in immune thrombocytopenia.
    The Lancet. Haematology, 2021, Volume: 8, Issue:4

    Topics: Dexamethasone; Health Services Needs and Demand; Humans; Oseltamivir; Purpura, Thrombocytopenic, Idiopathic; Thrombocytopenia

2021
Successful treatment with oseltamivir phosphate in a patient with chronic immune thrombocytopenia positive for anti-GPIb/IX autoantibody.
    Platelets, 2015, Volume: 26, Issue:5

    Topics: Aged; Autoantibodies; Humans; Male; Oseltamivir; Platelet Count; Platelet Glycoprotein GPIb-IX Complex; Purpura, Thrombocytopenic, Idiopathic; Treatment Outcome

2015
Thrombopoietin receptor agonists in conjunction with oseltamivir for immune thrombocytopenia.
    AIDS (London, England), 2016, Apr-24, Volume: 30, Issue:7

    Topics: Anti-HIV Agents; HIV Infections; Humans; Male; Middle Aged; Oseltamivir; Purpura, Thrombocytopenic, Idiopathic; Receptors, Fc; Receptors, Thrombopoietin; Recombinant Fusion Proteins; Thrombopoietin; Treatment Outcome

2016
An experience of oseltamivir phosphate (tamiflu™) in a pediatric patient with chronic idiopathic thrombocytopenic purpura: a case report.
    Pathophysiology of haemostasis and thrombosis, 2010, Volume: 37, Issue:2-4

    Topics: Adolescent; Antiviral Agents; Chronic Disease; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Oseltamivir; Platelet Count; Purpura, Thrombocytopenic, Idiopathic

2010